NCIt definition : A steroidal compound with antiandrogen activity. Abiraterone inhibits the enzymatic
activity of steroid 17alpha-monooxygenase (17alpha-hydrolase/C17,20 lyase complex;
CYP17A1), a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation
of steroid intermediates involved in testosterone synthesis. Administration of this
agent may suppress testosterone production by both the testes and the adrenals to
castrate-range levels.;
UNII : G819A456D0;
InChIKey : GZOSMCIZMLWJML-VJLLXTKPSA-N;
CAS number : 154229-19-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 154229-19-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
https://www.has-sante.fr/jcms/p_3516751/fr/akeega-niraparib/acetate-d-abiraterone-cancer-de-la-prostate 2024 France evaluation of the transparency committee abiraterone prostatism, nos Prostate Carcinoma prostatic neoplasms Prostate Cancer pT2c TNM Finding v6 and v7 NCI CTEP SDC Prostate Cancer Sub-Category Terminology Prostate Cancer Pathway prostate cancer neoplasm, malignant prostate, nos Abiraterone abiraterone malignant neoplasm prostate